JSL
GILD icon

JT Stratford LLC’s Gilead Sciences GILD Stock Holding History

JT Stratford LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,271
Closed -$1.18M – 238
2023
Q1 		$1.18M Buy
14,271
+430
+3% +$35.6K 0.34% 84
2022
Q4 		$1.19M Buy
+13,841
New +$1.1M 0.38% 72
2020
Q4 		– Sell
-14,571
Closed -$921K – 190
2020
Q3 		$921K Sell
14,571
-2,197
-13% -$152K 0.4% 64
2020
Q2 		$1.29M Sell
16,768
-1,689
-9% -$129K 0.66% 52
2020
Q1 		$1.38M Buy
+18,457
New +$1.28M 0.85% 36
2017
Q1 		– Sell
-3,489
Closed -$250K – 111
2016
Q4 		$250K Buy
+3,489
New +$259K 0.21% 91

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JT Stratford LLC's GILD Position: Q2 2023 in Review

JT Stratford LLC sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 14,271 shares — an estimated $1.18M sold.

JT Stratford LLC first reported a position in GILD in Q4 2016 and held it in 6 quarters. The position peaked at $1.38M in Q1 2020. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • JT Stratford LLC reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • JT Stratford LLC sold 14,271 Gilead Sciences shares in Q2 2023, an estimated $1.18M.
  • JT Stratford LLC first reported a position in Gilead Sciences in Q4 2016 and held it in 6 quarters.
  • JT Stratford LLC's Gilead Sciences position peaked at $1.38M in Q1 2020.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on JT Stratford LLC's 13F filing for Q2 2023, filed 14 Aug 2023.